170 related articles for article (PubMed ID: 17047060)
1. Activation of EDTA-resistant gelatinases in malignant human tumors.
Chen D; Kennedy A; Wang JY; Zeng W; Zhao Q; Pearl M; Zhang M; Suo Z; Nesland JM; Qiao Y; Ng AK; Hirashima N; Yamane T; Mori Y; Mitsumata M; Ghersi G; Chen WT
Cancer Res; 2006 Oct; 66(20):9977-85. PubMed ID: 17047060
[TBL] [Abstract][Full Text] [Related]
2. Seprase: an overview of an important matrix serine protease.
O'Brien P; O'Connor BF
Biochim Biophys Acta; 2008 Sep; 1784(9):1130-45. PubMed ID: 18262497
[TBL] [Abstract][Full Text] [Related]
3. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease.
Piñeiro-Sánchez ML; Goldstein LA; Dodt J; Howard L; Yeh Y; Tran H; Argraves WS; Chen WT
J Biol Chem; 1997 Mar; 272(12):7595-601. PubMed ID: 9065413
[TBL] [Abstract][Full Text] [Related]
4. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma.
Mori Y; Kono K; Matsumoto Y; Fujii H; Yamane T; Mitsumata M; Chen WT
Oncology; 2004; 67(5-6):411-9. PubMed ID: 15713998
[TBL] [Abstract][Full Text] [Related]
5. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers.
Kelly T; Kechelava S; Rozypal TL; West KW; Korourian S
Mod Pathol; 1998 Sep; 11(9):855-63. PubMed ID: 9758365
[TBL] [Abstract][Full Text] [Related]
6. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
Goscinski MA; Suo ZH; Nesland JM; Chen WT; Zakrzewska M; Wang J; Zhang S; Flørenes VA; Giercksky KE
Oncology; 2008; 75(1-2):49-59. PubMed ID: 18787344
[TBL] [Abstract][Full Text] [Related]
7. Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.
Kennedy A; Dong H; Chen D; Chen WT
Int J Cancer; 2009 Jan; 124(1):27-35. PubMed ID: 18823010
[TBL] [Abstract][Full Text] [Related]
8. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast.
Ariga N; Sato E; Ohuchi N; Nagura H; Ohtani H
Int J Cancer; 2001 Jan; 95(1):67-72. PubMed ID: 11241314
[TBL] [Abstract][Full Text] [Related]
9. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells.
Monsky WL; Lin CY; Aoyama A; Kelly T; Akiyama SK; Mueller SC; Chen WT
Cancer Res; 1994 Nov; 54(21):5702-10. PubMed ID: 7923219
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of seprase: a serine integral membrane protease from human melanoma.
Goldstein LA; Ghersi G; Piñeiro-Sánchez ML; Salamone M; Yeh Y; Flessate D; Chen WT
Biochim Biophys Acta; 1997 Jul; 1361(1):11-9. PubMed ID: 9247085
[TBL] [Abstract][Full Text] [Related]
11. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
12. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).
Gilmore BF; Lynas JF; Scott CJ; McGoohan C; Martin L; Walker B
Biochem Biophys Res Commun; 2006 Jul; 346(2):436-46. PubMed ID: 16769036
[TBL] [Abstract][Full Text] [Related]
13. Expression of seprase in effusions from patients with epithelial ovarian carcinoma.
Zhang MZ; Qiao YH; Nesland JM; Trope C; Kennedy A; Chen WT; Suo ZH
Chin Med J (Engl); 2007 Apr; 120(8):663-8. PubMed ID: 17517181
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines.
Wilson CH; Abbott CA
Int J Oncol; 2012 Sep; 41(3):919-32. PubMed ID: 22736146
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer.
Iwasa S; Jin X; Okada K; Mitsumata M; Ooi A
Cancer Lett; 2003 Sep; 199(1):91-8. PubMed ID: 12963128
[TBL] [Abstract][Full Text] [Related]
16. A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation.
Osborne B; Yao TW; Wang XM; Chen Y; Kotan LD; Nadvi NA; Herdem M; McCaughan GW; Allen JD; Yu DM; Topaloglu AK; Gorrell MD
Biochim Biophys Acta; 2014 Jul; 1844(7):1248-59. PubMed ID: 24717288
[TBL] [Abstract][Full Text] [Related]
17. Seprase complexes in cellular invasiveness.
Chen WT; Kelly T
Cancer Metastasis Rev; 2003; 22(2-3):259-69. PubMed ID: 12785000
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis.
Levy MT; McCaughan GW; Abbott CA; Park JE; Cunningham AM; Müller E; Rettig WJ; Gorrell MD
Hepatology; 1999 Jun; 29(6):1768-78. PubMed ID: 10347120
[TBL] [Abstract][Full Text] [Related]
19. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
Rosenblum JS; Kozarich JW
Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
[TBL] [Abstract][Full Text] [Related]
20. Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors.
Mentlein R; Hattermann K; Hemion C; Jungbluth AA; Held-Feindt J
Biol Chem; 2011 Mar; 392(3):199-207. PubMed ID: 20707604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
